Evidence map›Paper›PMID 30944799›Full record

Article3 Biotech2019

Transcriptome-wide analysis of the difference of alternative splicing in susceptible and resistant silkworm strains after BmNPV infection.

Gang Li, Kaiyue Zhou, Guodong Zhao, Heying Qian, Anying Xu

Open access · bronzeAbstract read
In one paragraph

Article in 3 Biotech, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. High-QualityFrontiers in genetics · 2021
    Article
  7. Review
  8. SGID: a comprehensive and interactive database of the silkworm.Database : the journal of biological databases and curation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gang Li1Jiangsu University of Science and Technology, Zhenjiang, 212018 Jiangsu People's Republic of China.
Kaiyue Zhou1Jiangsu University of Science and Technology, Zhenjiang, 212018 Jiangsu People's Republic of China.
Guodong Zhao1Jiangsu University of Science and Technology, Zhenjiang, 212018 Jiangsu People's Republic of China.
Heying Qian1Jiangsu University of Science and Technology, Zhenjiang, 212018 Jiangsu People's Republic of China.
Anying Xu1Jiangsu University of Science and Technology, Zhenjiang, 212018 Jiangsu People's Republic of China.
Jiangsu University of Science and Technology · CNSericultural Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel alternative splicing events were identified from BmNPV-susceptible and -resistant silkworm strains after BmNPV infection using high-throughput RNA-sequencing strategy. In total, 12.82 Gb clean RNA-seq data were generated for the two midgut samples from BmNPV-susceptible and -resistant silkworm strains, and 14.78 Gb clean data for the two fat body samples. The number of alternative splicing events and isoforms in the BmNPV-susceptible silkworm strain was more than that in the BmNPV-resistant silkworm strain. Furthermore, alternative splicing genes uniquely present in BmNPV-resistant silkworm strain were involved in functions about ribosome, whereas, alternative splicing genes uniquely present in BmNPV-susceptible silkworm strain were implicated in functions like DNA helicase activity and signal transduction. Additionally, 33 expressed SR or SR-like proteins were identified, and three genes encoding SR or SR-like proteins (

Indexed as

Alternative splicingBombyx mori nucleopolyhedrovirusRNA-sequencingSR proteins

Identifiers

PMID30944799
PMCPMC6434002
OpenAlexW2938000227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.